Method of inhibition of HIV replication by leukemia inhibitory factor
US6235304A · kind A · utility
1Cited by
1References
15Claims
0Family size
Inventor
Key dates
| Filing date | Nov 19, 1999 |
| Grant date | May 22, 2001 |
| Priority date | — |
| Expiry date | Nov 19, 2019 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P31/18
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention concerns a method for inhibiting HIV replication in a cell by binding Leukemia Inhibitory Factors ("LIF") LIF to its receptor in a cell to inhibit HIV replication within the cell. In addition, the present invention concerns a method for preventing uninfected individuals from infection with HIV by administering a dosage of LIF to prevent establishment of HIV infection. The present invention also provides a method of treating HIV infected individuals by administering a dosage of LIF to prevent disease progression.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.